{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:22:12Z","timestamp":1790241732343,"version":"4.1.0"},"reference-count":47,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2014.0809","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T05:19:26Z","timestamp":1525238366000},"source":"Crossref","is-referenced-by-count":20,"title":["Platelet Transfusion in Hematology, Oncology and Surgery"],"prefix":"10.3238","author":[{"given":"Hannes","family":"Wandt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Sch\u00e4fer-Eckart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Greinacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2014,11,28]]},"reference":[{"key":"10.3238\/arztebl.2014.0809_ref1","doi-asserted-by":"crossref","unstructured":"Gaydos LA, Freirecht EJ, Mantel N: The quantitative relation between platelet count and hemorrhage in patients with acute leukemia. N Engl J Med 1962; 266: 905\u20139.","DOI":"10.1056\/NEJM196205032661802"},{"key":"10.3238\/arztebl.2014.0809_ref2","doi-asserted-by":"crossref","unstructured":"Gm\u00fcr J, Burger J, Schanz U, Fehr J, Schaffner A: Safety of stringent prophylactis platelet transfusion policy for patients with acute leukemia. Lancet 1991; 338: 1223\u20136.","DOI":"10.1016\/0140-6736(91)92098-M"},{"key":"10.3238\/arztebl.2014.0809_ref3","doi-asserted-by":"crossref","unstructured":"Rebulla P, Finanzzi G, Marangoni F, et al.: The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell\u00b4Adulto. N Engl J Med 1997; 337: 1870\u20135.","DOI":"10.1056\/NEJM199712253372602"},{"key":"10.3238\/arztebl.2014.0809_ref4","doi-asserted-by":"crossref","unstructured":"Wandt H, Frank M, Ehninger G, et al.: Safety and cost effectiveness of a 10x10(9)\/L trigger for prophylactic platelet transfusions compared with the traditional 20x10(9)\/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. Blood 1998; 91: 3601\u20136.","DOI":"10.1182\/blood.V91.10.3601.3601_3601_3606"},{"key":"10.3238\/arztebl.2014.0809_ref5","doi-asserted-by":"crossref","unstructured":"Schiffer CA, Anderson KC, Bennet CL, et al.: Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001; 19: 1519\u201338.","DOI":"10.1200\/JCO.2001.19.5.1519"},{"key":"10.3238\/arztebl.2014.0809_ref6","unstructured":"Bundes\u00e4rztekammer: Querschnitts-Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten. 4. Auflage. K\u00f6n: Deutscher \u00c4rzte-Verlag 2009."},{"key":"10.3238\/arztebl.2014.0809_ref7","doi-asserted-by":"crossref","unstructured":"Friedmann AM, Sengul H, Lehmann H, Schwartz C, Goodman S: Do basic laboratoy test of clinical observations predict bleeding in thrombocytopenic oncology patients? A re-evaluation of prophylactic platelet transfusions. Transfus Med Rev 2002; 16: 34\u201345.","DOI":"10.1053\/tmrv.2002.29403"},{"key":"10.3238\/arztebl.2014.0809_ref8","doi-asserted-by":"crossref","unstructured":"Slichter SJ: Relationship between platelet count and bleeding risk in thrombocytopenic patients. Transfus Med Rev 2004; 18: 153\u201367.","DOI":"10.1016\/j.tmrv.2004.03.003"},{"key":"10.3238\/arztebl.2014.0809_ref9","doi-asserted-by":"crossref","unstructured":"Estcourt L, Stanworth S, Doree C, et al.: Prpophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation: Cochrane Database Syst Rev 2012; 5: CD004269.","DOI":"10.1002\/14651858.CD004269.pub3"},{"key":"10.3238\/arztebl.2014.0809_ref10","doi-asserted-by":"crossref","unstructured":"Schiffer CA: Prophylactic platelet transfusion is frequently not necessary. Nat Rev Clin Oncol 2013; 10: 431\u20132.","DOI":"10.1038\/nrclinonc.2013.113"},{"key":"10.3238\/arztebl.2014.0809_ref11","doi-asserted-by":"crossref","unstructured":"Sagemeister M, Oec L, Gm\u00fcr J: A restrictive platelet transfusion policy allowing long-term support of outpatients with severe aplastic anemia. Blood 1999; 93: 3124\u20136.","DOI":"10.1182\/blood.V93.9.3124"},{"key":"10.3238\/arztebl.2014.0809_ref12","doi-asserted-by":"crossref","unstructured":"Wandt H, Schaefer-Eckart K, Wendelin K, et al.: Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomized study. Lancet 2012; 380: 1309\u201316.","DOI":"10.1016\/S0140-6736(12)60689-8"},{"key":"10.3238\/arztebl.2014.0809_ref13","doi-asserted-by":"crossref","unstructured":"Stanworth SJ, Estcourt LJ, Powter G, et al.: A no-prophylaxis platelet-transfusion strategy for hematologic cancers. N Engl J Med 2013; 368: 1771\u201380.","DOI":"10.1056\/NEJMoa1212772"},{"key":"10.3238\/arztebl.2014.0809_ref14","doi-asserted-by":"crossref","unstructured":"Wandt H, Schaefer-Eckart K, Frank M, Birkmann J, Wilhelm M: A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2006; 37: 387\u201392.","DOI":"10.1038\/sj.bmt.1705246"},{"key":"10.3238\/arztebl.2014.0809_ref15","doi-asserted-by":"crossref","unstructured":"Estcourt LJ: Why has demand for platelet component increased? Areview. Transfus Med 2014; in press.","DOI":"10.1111\/tme.12155"},{"key":"10.3238\/arztebl.2014.0809_ref16","doi-asserted-by":"crossref","unstructured":"Blumberg N, Heal JM, Phillips GL, Phipps RP: Platelets \u2013 to transfuse or not to transfuse. Lancet 2012; 380: 1287\u20139.","DOI":"10.1016\/S0140-6736(12)60983-0"},{"key":"10.3238\/arztebl.2014.0809_ref17","doi-asserted-by":"crossref","unstructured":"Refaai MA, Phipps RP, Spinelli SL, Blumberg N: Platelet transfusions: impact on hemostasis, thrombosis, inflammation and clinical outcomes. Thromb Res 2011; 127: 287\u201391.","DOI":"10.1016\/j.thromres.2010.10.012"},{"key":"10.3238\/arztebl.2014.0809_ref18","doi-asserted-by":"crossref","unstructured":"British Committee for Standards in Haematology, Blood Transfusion Task Force:Guidelines for the use of platelet transfusions. Br J Haemat 2003; 122: 10\u201323.","DOI":"10.1046\/j.1365-2141.2003.04468.x"},{"key":"10.3238\/arztebl.2014.0809_ref19","doi-asserted-by":"crossref","unstructured":"Greinacher A, Kiefel V, Kl\u00fcter H, Kroll H, P\u00f6tzsch B, Riess H: Empfehlung zur Thrombozytentransfusion der Thrombozyten-Arbeitsgruppe der DGTI, GTH und DGHO. Transfus Med Hemother 2006; 33: 528\u201343.","DOI":"10.1159\/000096293"},{"key":"10.3238\/arztebl.2014.0809_ref20","doi-asserted-by":"crossref","unstructured":"Neunert C, Lim W, Crowther M, Cohen A, Solberg Jr L, Crowther MA: The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011; 117: 4190\u2013207.","DOI":"10.1182\/blood-2010-08-302984"},{"key":"10.3238\/arztebl.2014.0809_ref21","doi-asserted-by":"crossref","unstructured":"Slichter SJ, Kaufman RM, Assmann SF, et al.: Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med 2010; 362: 600\u201313.","DOI":"10.1056\/NEJMoa0904084"},{"key":"10.3238\/arztebl.2014.0809_ref22","doi-asserted-by":"crossref","unstructured":"Stanworth SJ, Estcourt LJ, Llewelyn CA, Murphy MF, Wood EM: Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial. Transfusion 2014; doi: 10.1111\/trf.12646. [Epub ahead of print].","DOI":"10.1111\/trf.12646"},{"key":"10.3238\/arztebl.2014.0809_ref23","doi-asserted-by":"crossref","unstructured":"Elting LS, Martin CG, Kurtin DJ, et al.: The bleeding risk index: a clinical prediction rule to guide the prophylactic use of platelet transfusions in patients with lymphoma or solid tumors. Cancer 2002; 94: 3252\u201362.","DOI":"10.1002\/cncr.10603"},{"key":"10.3238\/arztebl.2014.0809_ref24","doi-asserted-by":"crossref","unstructured":"Carrier M, Khorana AA, Zwicker J, Noble S, Lee AY: Subcommittee on haemostasis and malignancy for the SSC of the ISTH: Management of challenging cases of patients with cancer-associated thrombosis including recurrent thrombosis and bleeding: guidance from the SSC of the ISTH. J Thromb Haemost 2013; 11: 1760\u20135.","DOI":"10.1111\/jth.12338"},{"key":"10.3238\/arztebl.2014.0809_ref25","doi-asserted-by":"crossref","unstructured":"Lyman GH, Khorana AA, Kuderer NM, et al.: Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline udate. J Clin Oncol 2013; 31: 2189\u2013204.","DOI":"10.1200\/JCO.2013.49.1118"},{"key":"10.3238\/arztebl.2014.0809_ref26","doi-asserted-by":"crossref","unstructured":"Matzdorff A, Beer JH: Immun thrombocytopenia patients requiring anticoagulation \u2013 maneuvering between Scylla and Charybdis. Sem Hematol 2013; 50: 83\u20138.","DOI":"10.1053\/j.seminhematol.2013.03.020"},{"key":"10.3238\/arztebl.2014.0809_ref27","doi-asserted-by":"crossref","unstructured":"Wada H, Matsumoto T, Yamashita Y: Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four guidelines. J Intensive Care 2014; 2: 15.","DOI":"10.1186\/2052-0492-2-15"},{"key":"10.3238\/arztebl.2014.0809_ref28","doi-asserted-by":"crossref","unstructured":"Duffy SM, Coyle TE: Platelet transfusions and bleeding complications associated with plasma exchange catheter placement in patients with presumed thrombotic thrombocytopenic purpura. J Clin Apher 2013; 28: 356\u20138.","DOI":"10.1002\/jca.21279"},{"key":"10.3238\/arztebl.2014.0809_ref29","doi-asserted-by":"crossref","unstructured":"Zeidler K, Arn K, Senn O, Schanz U, Stussi G: Optimal preprocedural platelet transfusion threshold for central venous catheter insertions in patients with thrombocytopenia.Transfusion 2011; 51: 2269\u201376.","DOI":"10.1111\/j.1537-2995.2011.03147.x"},{"key":"10.3238\/arztebl.2014.0809_ref30","doi-asserted-by":"crossref","unstructured":"Avricka SR, Walter RB, Irani S, Halter J, Schanz U: Safety of lumbarpuncture for adults with acute leukemia and restrictive prophylacticplatelet transfusion. Ann Hematol 2003; 82: 570\u20133.","DOI":"10.1007\/s00277-003-0707-0"},{"key":"10.3238\/arztebl.2014.0809_ref31","doi-asserted-by":"crossref","unstructured":"Stanworth SJ, Walsh TS, Prescott RJ, Lee RJ, Watson DM, Wyncoll DL: Intensive care study of coagulopathy investigators. Thrombocytopenia and platelet transfusion in UK critical care:a multicenter observational study. Transfusion 2013; 53: 1050\u20138.","DOI":"10.1111\/j.1537-2995.2012.03866.x"},{"key":"10.3238\/arztebl.2014.0809_ref32","doi-asserted-by":"crossref","unstructured":"McIntyre L, Tinmouth AT, Fergusson DA: Blood component transfusion in critically ill patients. Curr Opin Crit Care 2013; 19: 326\u201333.","DOI":"10.1097\/MCC.0b013e3283632e56"},{"key":"10.3238\/arztebl.2014.0809_ref33","doi-asserted-by":"crossref","unstructured":"Arnold DM, Crowther MA, Cook RJ, et al.: Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses. Transfusion 2006; 46: 1286\u201391.","DOI":"10.1111\/j.1537-2995.2006.00892.x"},{"key":"10.3238\/arztebl.2014.0809_ref34","doi-asserted-by":"crossref","unstructured":"Dellinger RP, Levy MM, Rhodes A, et al.: Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013; 39: 165\u2013228.","DOI":"10.1007\/s00134-012-2769-8"},{"key":"10.3238\/arztebl.2014.0809_ref35","doi-asserted-by":"crossref","unstructured":"Lieberman L, Bercovitz RS, Sholapur NS, Heddle NM, Stanworth SJ, Arnold DM: Platelet transfusions for critically ill patients with thrombocytopenia. Blood 2014; 123: 1146\u201351.","DOI":"10.1182\/blood-2013-02-435693"},{"key":"10.3238\/arztebl.2014.0809_ref36","doi-asserted-by":"crossref","unstructured":"Slichter SJ, Davis K, Enright H, et al.: Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood 2005; 105: 4106\u201314.","DOI":"10.1182\/blood-2003-08-2724"},{"key":"10.3238\/arztebl.2014.0809_ref37","doi-asserted-by":"crossref","unstructured":"Wardrop D, Estcourt LJ, Brunskill SJ, et al.: Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders. Cochrane Database Syst Rev 2013; 7: CD009733.","DOI":"10.1002\/14651858.CD009733.pub2"},{"key":"10.3238\/arztebl.2014.0809_ref38","doi-asserted-by":"crossref","unstructured":"Schrezenmeier H, Seifried E: Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred? Vox Sang 2010; 99: 1\u201315.","DOI":"10.1111\/j.1423-0410.2009.01295.x"},{"key":"10.3238\/arztebl.2014.0809_ref39","doi-asserted-by":"crossref","unstructured":"Hitzler WE: Single-donor (apheresis) platelets and pooled whole-blood-derived platelets \u2013 significance and assessment of both blood products. Clin Lab 2014; 60: 1\u201339.","DOI":"10.7754\/Clin.Lab.2014.140210"},{"key":"10.3238\/arztebl.2014.0809_ref40","doi-asserted-by":"crossref","unstructured":"Thiele T, Heddle NM, Greinacher A: Donor exposures in recipients of pooled platelet concentrates. N Engl J Med 2013; 368: 487\u20139.","DOI":"10.1056\/NEJMc1213383"},{"key":"10.3238\/arztebl.2014.0809_ref41","doi-asserted-by":"crossref","unstructured":"Lee AY: Anticoagulation in the treatment of established venous thromboembolism in patients with cancer. J Clin Oncol 2009; 27: 4695\u2013901.","DOI":"10.1200\/JCO.2009.22.3958"},{"key":"10.3238\/arztebl.2014.0809_ref42","doi-asserted-by":"crossref","unstructured":"Russo A, Cannizzo M, Ghetti G, et al.: Idiopathic thrombocytopenia purpura and coronary artery disease: comparision between coronary artery bypass grafting and percutaneous coronary intervention. Interact Cardiovasc Thorac Surg 2011; 13: 153\u20137.","DOI":"10.1510\/icvts.2011.271296"},{"key":"10.3238\/arztebl.2014.0809_ref43","unstructured":"Oliveira W, Meireles GC, Pimenta J: Elective coronary stent implantation in a patient with unstable angina and thrombocytopenia. J Invasive Cardiol 2005; 17: 393\u20134."},{"key":"10.3238\/arztebl.2014.0809_ref44","doi-asserted-by":"crossref","unstructured":"Eklund EA: Thrombocytopenia and cancer. Cancer Treat Res 2009;148: 279\u201393.","DOI":"10.1007\/978-0-387-79962-9_16"},{"key":"10.3238\/arztebl.2014.0809_ref45","doi-asserted-by":"crossref","unstructured":"Antun AG, Gleason S, Arellano M, et al.: Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies. Cancer 2013; 119: 3784\u20137.","DOI":"10.1002\/cncr.28253"},{"key":"10.3238\/arztebl.2014.0809_ref46","doi-asserted-by":"crossref","unstructured":"Dumont LJ, Szczepiorkowski ZM: Pooled platelet concentrates or apheresis platelets? N Engl J Med 2013; 368: 1848\u20139.","DOI":"10.1056\/NEJMc1302634"},{"key":"10.3238\/arztebl.2014.0809_ref47","doi-asserted-by":"crossref","unstructured":"Triulzi DJ, Assmann SF, Strauss RG, et al.: The impact of platelet transfusion characteristics on posttransfusion platelet increments and clinical bleeding in patients with hypoproliferative thrombocytopenia. Blood 2012; 119: 5553\u201362.","DOI":"10.1182\/blood-2011-11-393165"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2014.0809","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T09:00:57Z","timestamp":1638781257000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2014.0809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,28]]},"references-count":47,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2014.0809","relation":{"is-cited-by":[{"id-type":"doi","id":"10.1007\/978-3-319-44025-5_2","asserted-by":"object"}]},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,28]]}}}